Who owns Ngm Biopharmaceuticals Inc?
- Ticker: NGM
- CUSIP Number: 62921n105
Tip: Access positions for across all investors
Analyze quarterly positions in Ngm Biopharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ngm Biopharmaceuticals stock
Who bought or sold Ngm Biopharmaceuticals Inc this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Column Group | 18M | $29M | 0% | Mar 2024 |
|
| BlackRock | 3.0M | $4.8M | -22% | Mar 2024 |
|
| Vanguard Group | 2.3M | $3.7M | -16% | Mar 2024 |
|
| StepStone | 1.6M | $2.5M | 0% | Mar 2024 |
|
| Euclidean Capital | 992k | $1.6M | 0% | Mar 2024 |
|
| Geode Capital Management | 984k | $1.6M | 11% | Mar 2024 |
|
| Trium Capital | 978k | $1.6M | 100% | Mar 2024 |
|
| ADAR1 Capital Management | 817k | $1.3M | 100% | Mar 2024 |
|
| Two Sigma Advisers | 506k | $804k | -14% | Mar 2024 |
|
| Northern Trust | 373k | $593k | 8% | Mar 2024 |
|
| Balyasny Asset Management | 361k | $573k | 100% | Mar 2024 |
|
| Federated Investors | 345k | $297k | -41% | Dec 2023 |
|
| Citadel Advisors | 343k | $546k | 373% | Mar 2024 |
|
| Charles Schwab Investment Management | 285k | $453k | 2% | Mar 2024 |
|
| Goldman Sachs Group | 209k | $333k | 89% | Mar 2024 |
|
| Exchange Traded Concepts | 186k | $296k | 74% | Mar 2024 |
|
| Natixis | 181k | $288k | 100% | Mar 2024 |
|
| Bnp Paribas Arbitrage, Snc | 171k | $273k | -22% | Mar 2024 |
|
| Morgan Stanley | 156k | $247k | -67% | Mar 2024 |
|
| Dimensional Fund Advisors | 155k | $246k | 0% | Mar 2024 |
|
| Bank of New York Mellon | 133k | $212k | -4% | Mar 2024 |
|
| Citigroup | 108k | $171k | 1355% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 98k | $156k | 100% | Mar 2024 |
|
| Nuveen Asset Management | 94k | $150k | -85% | Mar 2024 |
|
| Hennion & Walsh Asset Management | 71k | $112k | 7% | Mar 2024 |
|
| Rhumbline Advisers | 66k | $106k | 2% | Mar 2024 |
|
| Millennium Management | 66k | $105k | -95% | Mar 2024 |
|
| Alliancebernstein | 64k | $55k | -6% | Dec 2023 |
|
| Virtu Financial | 49k | $77k | 100% | Mar 2024 |
|
| Jane Street | 48k | $77k | -18% | Mar 2024 |
|
| OTR - Nominee Name for The State Teachers Retirement Board of Ohio | 46k | $73k | -6% | Mar 2024 |
|
| UBS Group | 45k | $72k | -3% | Mar 2024 |
|
| FMR | 35k | $56k | -43% | Mar 2024 |
|
| GSA Capital Partners | 34k | $53k | -90% | Mar 2024 |
|
| Barclays | 30k | $48k | -67% | Mar 2024 |
|
| Diker Management | 30k | $48k | 100% | Mar 2024 |
|
| Two Sigma Investments | 28k | $44k | -94% | Mar 2024 |
|
| Clarius | 27k | $43k | 1% | Mar 2024 |
|
| XTX Topco | 26k | $41k | -27% | Mar 2024 |
|
| Bank of America Corporation | 26k | $41k | -55% | Mar 2024 |
|
| Tudor Investment Corporation | 25k | $40k | 0% | Mar 2024 |
|
| Carson Advisory | 23k | $36k | 0% | Mar 2024 |
|
| Engineers Gate Manager | 22k | $35k | 102% | Mar 2024 |
|
| American International | 22k | $19k | 0% | Dec 2023 |
|
| Mirae Asset Global Investments | 21k | $81k | 100% | Mar 2024 |
|
| Principal Financial Group | 20k | $32k | 4% | Mar 2024 |
|
| Oxford Asset Management | 20k | $31k | 100% | Mar 2024 |
|
| Jasper Ridge Partners | 19k | $31k | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 19k | $29k | -35% | Mar 2024 |
|
| AQR Capital Management | 17k | $28k | 100% | Mar 2024 |
|
| Cubist Systematic Strategies | 16k | $25k | 100% | Mar 2024 |
|
| Florida State Board of Administration | 16k | $64k | 38% | Mar 2024 |
|
| Wells Fargo & Company | 15k | $25k | 11% | Mar 2024 |
|
| SG Americas Securities | 15k | $24k | -36% | Mar 2024 |
|
| JustInvest | 12k | $19k | 100% | Mar 2024 |
|
| T. Rowe Price Associates | 11k | $18k | 8% | Mar 2024 |
|
| New York State Common Retirement Fund | 10k | $16k | 0% | Mar 2024 |
|
| California State Teachers Retirement System | 4.4k | $7.0k | -54% | Mar 2024 |
|
| Tower Research Capital | 3.7k | $5.8k | -87% | Mar 2024 |
|
| Cutler | 3.4k | $4.4k | 10% | Mar 2024 |
|
| Summit Investment Advisors | 3.1k | $5.0k | 0% | Mar 2024 |
|
| Legal & General Group | 3.0k | $4.8k | 0% | Mar 2024 |
|
| Amalgamated Bank | 1.4k | $2.0k | -63% | Mar 2024 |
|
| Royal Bank of Canada | 1.1k | $0 | -91% | Mar 2024 |
|
| Group One Trading | 1.1k | $1.7k | 133% | Mar 2024 |
|
| Capital Advisors | 777.00 | $999.999000 | 100% | Mar 2024 |
|
| GAMMA Investing | 346.00 | $550.001600 | 0% | Mar 2024 |
|
| Farther Finance Advisors | 96.00 | $150.000000 | 100% | Mar 2024 |
|
| NISA Investment Advisors | 75.00 | $119.002500 | 0% | Mar 2024 |
|
| Covestor | 62.00 | $0 | -5% | Mar 2024 |
|
| Simplex Trading | 28.00 | $0 | -81% | Mar 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 7.00 | $10.999800 | 100% | Mar 2024 |
|
| CWM | 6.00 | $0 | -99% | Mar 2024 |
|
Who sold out of Ngm Biopharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| EcoR1 Capital | Dec 2023 | 2.4M | $2.0M |
| Acadian Asset Management | Sep 2023 | 1.2M | $1.3M |
| Jacobs Levy Equity Management | Dec 2023 | 556k | $478k |
| D. E. Shaw & Co | Dec 2023 | 308k | $265k |
| Bridgeway Capital Management | Sep 2023 | 275k | $294k |
| Deutsche Bank Aktiengesellschaft | Dec 2023 | 213k | $183k |
| Squarepoint Ops | Dec 2023 | 213k | $183k |
| Man Group | Dec 2023 | 120k | $103k |
| Susquehanna International | Sep 2023 | 84k | $90k |
| Ameriprise Financial | Sep 2023 | 81k | $87k |
| State of Wisconsin Investment Board | Dec 2023 | 69k | $59k |
| Mackenzie Financial | Dec 2023 | 63k | $54k |
| Ohio Pers | Dec 2023 | 48k | $42k |
| Russell Investments | Dec 2023 | 44k | $38k |
| Susquehanna Fundamental Investments | Sep 2023 | 42k | $45k |
| Algert Coldiron Investors | Sep 2023 | 37k | $40k |
| Raymond James & Associates | Dec 2023 | 21k | $18k |
| Qube Research & Technologies | Sep 2023 | 17k | $18k |
| Hrt Financial | Dec 2023 | 13k | $11k |
| Us Bancorp | Dec 2023 | 13k | $11k |
| Walleye Trading Advisors | Dec 2023 | 12k | $11k |
| ProShare Advisors | Sep 2023 | 11k | $12k |
| Quantbot Technologies | Sep 2023 | 5.3k | $5.7k |